Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 13Phase 1/2 9Phase 3 4Phase EARLY_PHASE1 1

Status

Recruiting 16Active not recruiting 10Completed 9Terminated 4Unknown 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4

Conditions

Multiple Myeloma 4

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Terminated × pomalidomide × Clear all
NCT05675319 2026-01-05

AlloRelapseMM

Universitätsklinikum Hamburg-Eppendorf

Phase 3 Terminated
28 enrolled
Plasma cell

Multiple Myeloma

NCT03151811 2024-01-30

OCEAN

Oncopeptides AB

Phase 3 Terminated
495 enrolled 15 charts
Plasma cell

Multiple Myeloma

NCT02576977 2021-10-08

KEYNOTE 183

Merck Sharp & Dohme LLC

Phase 3 Terminated
251 enrolled 17 charts
Plasma cell

Multiple Myeloma

NCT03440411 2021-03-10

PO-3887

Fondazione EMN Italy Onlus

Phase 3 Terminated
9 enrolled 20 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡